Holista Colltech Limited (ASX:HCT)

Market Cap	28.32M +560.8%
Revenue (ttm)	5.83M +6.8%
Net Income	600.70K
EPS	0.00
Shares Out	367.83M
PE Ratio	39.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	92
Average Volume	45,079
Open	0.0770
Previous Close	0.0770
Day's Range	0.0770 - 0.0770
52-Week Range	0.0210 - 0.1100
Beta	1.36
RSI	41.40
Earnings Date	Feb 26, 2026

About Holista Colltech

Holista Colltech Limited operates as a research-driven biotech company in Australia, Malaysia, and the United States. The company operates through Supplements, Ovine Collagen, Infection Control Solutions, Food Ingredients, and Corporate segments. It manufactures and wholesales dietary supplements; cosmetic grade collagen; infection control solutions; and healthy food ingredients, including low-glycemic index (GI) bread, noodles/pasta, and flatbreads, as well as low-calorie/low-GI sugar substitutes. Further, it provides GI LiTE, a premix glycemi...

• Industry: Packaged Foods
• Sector: Consumer Staples
• CEO: Leong Loong
• Employees: 58
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HCT

Financial Performance

In 2024, Holista Colltech's revenue was 5.60 million, a decrease of -5.86% compared to the previous year's 5.95 million. Losses were -84,214, -98.25% less than in 2023.